Information Provided By: 
Fly News Breaks for July 12, 2017
DBD
Jul 12, 2017 | 08:05 EDT
Following the guidance reduction, Credit Suisse analyst Paul Condra believes the selloff was "a bit overdone" and expects the stock could regain some lost ground in the near-term. However, the move closer to $30 is likely to be mid to longer-term, he contends. Condra reiterates an Outperform rating and $26 price target on the shares.
News For DBD From the Last 2 Days
There are no results for your query DBD
